232sek
-2,1 %
Date:2024-04-19Time:09:09:40Latest report:Q4-2023List:First NorthTicker:SPEC
Market Cap:228 msekEnterprise Value:178 msekNet Sales:- msekEarnings:-20,4 msekEmployees:0ISIN:SE0007158118

Ratios

10-year key figure history for SpectraCure turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for SpectraCure with index and moving average MA50 and MA200.

Stockprice:2,32
MA50:2,72
MA200:3,89
Price/MA200:-39,7 %
RSI (14):42,1
Price/MA50:-13,7 %

Description

SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.

Medical Equipment